Financial Reviews

2023 Statements of Consolidated Financial Position
Assets 2023 2022
Cash and Cash Equivalents $211,978 $954,599
Investments 202,325,504 182,890,790
Investment-Related Receivables 751 581
Right of Use Asset (Net) 1,018,060 1,185,872
Prepaid Expenses and Other Assets 151,439 126,507
Total Assets $203,707,732 $185,158,349
Liabilities and Net Assets
Liabilities:
Accounts Payable and Accrued Expenses $23,961 $52,965
Grants Payable (Net) 1,582,690 464,242
Deferred Excise Tax Liability 507,052 212,632
Lease Liability 1,348,779 1,504,544
Total Liabilities 3,462,482 2,234,383
Net Assets:
Without Donor Restrictions 196,907,304 179,867,710
With Donor Restrictions 3,337,946 3,056,526
Total Net Assets 200,245,250 182,923,966
Total Liabilities and Net Assets 203,707,732 185,158,349
Consolidated Statement of Activities
Revenues and Gains (Losses) 2023 2022
Net Assets – Beginning of Year: $182,923,966 $224,084,414
Net Assets – End of Year: $200,245,250 $182,923,966
Investment Return (Net) 28,654,713 -32,406,748
Other Income 4,520 4,372
Total Revenues and Gains (Losses) 28,659,233 -32,402,376
Expenses    
Program Services 10,597,256 8,832,945
Management and General 348,288 310,236
Excise Tax Expense (Benefit) 392,405 -385,109
Total Expenses 11,337,949 8,758,072
Change in Net Assets 17,321,284 -41,160,448